RT Journal
A1 Lin G, Li Y, Han C
T1 TReatment with clopidogrel after myocardial infarction
JF JAMA
JO JAMA
YR 2012
FD December 19
VO 308
IS 23
SP 2456
OP 2457
DO 10.1001/jama.2012.28718
UL http://dx.doi.org/10.1001/jama.2012.28718
AB 
In a meta-analysis by Berger and colleagues,2 the risk reduction with clopidogrel in women was greatest for MI (odds ratio [OR], 0.81; 95% CI, 0.70-0.93) and not statistically significant for stroke (OR, 0.91; 95% CI, 0.69-1.21) or total death (OR, 0.99; 95% CI, 0.90-1.08). In contrast, the risk reduction with clopidogrel in men was not only significant for MI (OR, 0.83; 95% CI, 0.76-0.92), but also for stroke (OR, 0.83; 95% CI, 0.71-0.96) and total death (OR, 0.91; 95% CI, 0.84-0.97).2